NLS Pharmaceutics AG (NLSP)
Oct 30, 2025 - NLSP was delisted (reason: merged into NCEL)
0.7620
+0.0220 (2.97%)
Inactive · Last trade price on Oct 30, 2025
NLS Pharmaceutics AG Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 14, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $160 | Hold → Strong Buy | Upgrades | $160 | +20,897.38% | Dec 8, 2022 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2022 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $240 | Strong Buy | Initiates | $240 | +31,396.06% | Sep 6, 2022 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $480 | Strong Buy | Initiates | $480 | +62,892.13% | Mar 12, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $320 | Strong Buy | Initiates | $320 | +41,894.75% | Mar 3, 2021 |